glp-1 for anxiety A diabetes drug that quiets the anxious mind? receptor agonists are making waves far beyond weight loss — hitting five distinct brain pathways tied directly to anxiety: the stress axis, dopamine Study reveals GLP-1 medications may
Description
This gap highlights the clinical need for targeted nutritional counseling and, when necessary, supplementation
Data was retrieved for studies from inception up to 19 April 2022
(1)
[DOI] [PMC free article] [PubMed] [Google Scholar] 44.El Eid L., Reynolds C.A., Tomas A., Jones B
Ahrn B (2001) Inhibition of dipeptidyl peptidase-4 (DPP-4): a target to treat type 2 diabetes
First, you might benefit from a higher-potency compound like tirzepatide, which activates both the GLP-1 and GIP receptors and has demonstrated greater weight loss in head-to-head trials
